carbamazepine has been researched along with Cholangitis, Sclerosing in 2 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Visentin, M | 1 |
Lenggenhager, D | 1 |
Gai, Z | 1 |
Kullak-Ublick, GA | 1 |
Forbes, GM | 1 |
Jeffrey, GP | 1 |
Shilkin, KB | 1 |
Reed, WD | 1 |
1 review available for carbamazepine and Cholangitis, Sclerosing
Article | Year |
---|---|
Drug-induced bile duct injury.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bile Acids and Salts; Bile Ducts; Biomarkers; Biotran | 2018 |
1 other study available for carbamazepine and Cholangitis, Sclerosing
Article | Year |
---|---|
Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome.
Topics: Bile Ducts; Carbamazepine; Cholangitis, Sclerosing; Graft vs Host Disease; Humans; Liver; Liver Cirr | 1992 |